Status:
UNKNOWN
Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer
Lead Sponsor:
Ministry of Science and Technology of the People´s Republic of China
Collaborating Sponsors:
National Research Centre of Complementary and Alternative Medicine, Norway
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18-75 years
Brief Summary
Comprehensive therapy of traditional Chinese medicine (CTTCM) could relieve risk of recurrence and metastasis for stage II \& III colorectal cancer, the investigators take this clinical trial with ret...
Detailed Description
CTTCM: taking TCM decoction based on syndrome differentiation daily and each dosage is decocted two times for intervention one year with a Chinese patent medicine at least. CWMT: with or without chem...
Eligibility Criteria
Inclusion
- Patient who is diagnosed colorectal cancer by patho\& cytologic diagnosis since accepting radical operation within half a year.
- Stage II or III colorectal cancer.
- 18-75 yr.
- Being able to participate and sign the informed consent.
Exclusion
- Pregnant woman, Psychotic.
- Patient who put together with other cancer.
- Existed serious complaint and functional disturbance (impairment) with non-tumorous in arch-organ.
- Reactiveness cerebrovascular disease (CVD) .
- Uncontrolled infection and metabolic disease.
- One item of tumor marks is progressed, and it still is progressed when patient recheck.
- Tumor that it is neo-occurred in each organ or pelvic cavity or abdominal cavity without definite patho-quality.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2014
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT00689364
Start Date
April 1 2007
End Date
March 1 2014
Last Update
July 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xi-Yuan Hospital, China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China, 100091